Novartis Ag (NVSEF) EBT (QoQ) (2009 - 2023)

Novartis Ag (NVSEF) EBT (QoQ) (2009 - 2023) Analysis & Trends

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-
10	Novartis Ag	-	-	-

Historic Data

Download Data

Date	Value
Jun 30, 2023	-99.95%
Mar 31, 2023	106,054.98%
Dec 31, 2022	435.95%
Sep 30, 2022	-56.95%
Jun 30, 2022	113.60%
Mar 31, 2022	-83.95%
Dec 31, 2021	542.50%
Sep 30, 2021	-73.56%
Jun 30, 2021	-99.97%
Mar 31, 2021	285,109.17%
Dec 31, 2020	427.28%
Sep 30, 2020	-59.31%
Jun 30, 2020	1,079.38%
Jun 30, 2019	427.86%
Mar 31, 2019	-75.99%
Dec 31, 2018	24.88%
Sep 30, 2018	-79.75%
Jun 30, 2018	1,210.85%
Mar 31, 2018	-66.34%
Dec 31, 2017	-0.05%